| Date | Time | Source | Headline | Symbol | Company |
| 06/07/2024 | 2:15PM | iHub Newswire | FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio | | |
| 07/26/2011 | 5:09PM | Dow Jones News | Gilead Sciences 2Q Net Up 4.8% On Antiviral Product Sales | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2011 | 4:26PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2011 | 4:05PM | Business Wire | Gilead Sciences Announces Second Quarter 2011 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2011 | 11:30AM | Dow Jones News | IN THE PIPELINE: Gilead Looks To Extend HIV Lead With Drug Combo | NASDAQ:GILD | Gilead Sciences Inc |
| 07/25/2011 | 2:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/25/2011 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Comments on ConocoPhillips, Amazon, Las Vegas Sands, Gilead and Newmont Mining. | NASDAQ:GILD | Gilead Sciences Inc |
| 07/25/2011 | 9:00AM | Zacks | Earnings Preview: Gilead - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 07/22/2011 | 12:14PM | Dow Jones News | EARNINGS PREVIEW: US Biotechs Seen Posting Strong 2Q Results | NASDAQ:GILD | Gilead Sciences Inc |
| 07/22/2011 | 11:30AM | Zacks | Currency Mars Actelion 2Q - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2011 | 10:30AM | Business Wire | Gilead’s Investigational Antiretroviral Elvitegravir Once Daily Non-Inferior to Raltegravir Twice Daily at 48 Weeks | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2011 | 9:00AM | Marketwired | Research Report on Gilead Sciences, Inc. and Bristol-Myers Squibb Company - New Innovations Facilitate Recovery | NASDAQ:GILD | Gilead Sciences Inc |
| 07/19/2011 | 4:30PM | Business Wire | Gilead Sciences to Release Second Quarter 2011 Financial Results on Tuesday, July 26, 2011 | NASDAQ:GILD | Gilead Sciences Inc |
| 07/13/2011 | 11:15AM | Zacks | Mylan Gets HIV Rights from Gilead - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 07/12/2011 | 8:17AM | Dow Jones News | Mylan Strikes Deal With Gilead To Expand Licensing Pact | NASDAQ:GILD | Gilead Sciences Inc |
| 07/12/2011 | 5:03AM | Dow Jones News | Gilead First To Enter Patent Pool For Aids Drugs | NASDAQ:GILD | Gilead Sciences Inc |
| 07/12/2011 | 3:01AM | Business Wire | Gilead Expands Access Program for Medications in Developing World | NASDAQ:GILD | Gilead Sciences Inc |
| 07/11/2011 | 8:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/11/2011 | 3:46PM | Dow Jones News | UPDATE: Drug Firms, US Academia To Partner On HIV Projects | NASDAQ:GILD | Gilead Sciences Inc |
| 07/11/2011 | 1:48PM | Dow Jones News | Merck To Partner With US Universities On HIV Projects | NASDAQ:GILD | Gilead Sciences Inc |
| 07/08/2011 | 8:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/07/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for Pepsico, Gilead Sciences, Urban Outfitters, U.S. Bancorp, and Spreadtrum Communications Released by Seven Su | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2011 | 6:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2011 | 6:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2011 | 6:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2011 | 6:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 06/30/2011 | 10:45AM | Zacks | Gilead /JNJ to Make HIV Combo Drug - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 06/28/2011 | 3:21PM | Dow Jones News | UPDATE: J&J, Gilead Sign Deal For Combination HIV Therapy | NASDAQ:GILD | Gilead Sciences Inc |
| 06/28/2011 | 12:14PM | Dow Jones News | J&J, Gilead Sign Deal For Combination HIV Therapy | NASDAQ:GILD | Gilead Sciences Inc |
| 06/28/2011 | 8:30AM | Business Wire | Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop & Commercialize a New Fixed-Dose Combination of C... | NASDAQ:GILD | Gilead Sciences Inc |